RSS-Feed abonnieren
DOI: 10.1055/s-2001-17208
© Georg Thieme Verlag Stuttgart · New York
Enhancement of β-Cell Sensitivity to Glucose by Oral Fat Load
Publikationsverlauf
Publikationsdatum:
17. September 2001 (online)
Recent studies have demonstrated that 6 h infusions of lipid emulsion enhance insulin release, whereas 24 h infusions inhibit insulin secretion. How insulin release is modulated after oral fat loading has not yet been elucidated. 17 healthy fasting volunteers were subjected to 3 experiments in random order: test 1 was a frequently sampled i. v. glucose tolerance test (FSIVGTT, 0.3 g/kg glucose), test 2 began with the ingestion of 50 % sunflower oil (1.5 g/kg) followed by FSIVGTT 4 h later. Test 3 was identical to test 2 with i. v. addition of 100 U/kg heparin prior to FSIVGTT. Glucose and insulin data were analyzed by minimal model assumptions - glucose sensitivity of the β-cells (Θ1), acute insulin response (AIR) (10 min), 3 h insulin release (Θ2), glucose threshold of insulin secretion (h), insulin degradation rate (n), peripheral insulin sensitivity (SI), and glucose-dependent glucose disposal (SG). After drinking the fat emulsion, FFAs increased to 0.8 ± 0.3 mmol/l (test 2) and to 3.0 ± 0.3 mmol/l (test 3). Moderately increased FFA concentrations were associated with elevation of Θ1 (test 1, control 335 ± 157 vs. test 2: 859 ± 612 pM × min × mM-1, p = 0.030). At high plasma FFA levels and in the presence of heparin (test 3), Θ1 was reduced compared to test 2 and unchanged compared to test 1. Θ2 and h were elevated in both tests 2 and 3 compared to test 1. No changes of n, SI and SG were found. In conclusion, the ingestion of sunflower oil triglyceride emulsion resulted in a 60 % increase in plasma free fatty acids and enhanced the capacity of β-cells to secrete insulin. Heparin-induced high levels of FFA further augmented the total insulin release and inhibited parameters of glucose responsiveness.
Key words:
β-cell - Oral Fat - Free Fatty Acids
References
- 1 Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis. 1994; 106 83-97
- 2 Austin M A. Triacyglycerol and coronary heart disease. Proc Nutr Soc. 1997; 56 667-670
- 3 Groot P HE, Stiphout W AHJ, Krauss X H, et al. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb. 1991; 11 653-662
- 4 Zilversmit D B. Atherogenesis: a postprandial phenomenon. Circulation. 1979; 60 473-485
- 5 Reaven G M. Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes. 1988; 37 1595-1607
- 6 Schrezenmeir J, Fenselau S, Keppler I, et al. Postprandial triglyceride high response and the metabolic syndrome. Ann N Y Acad Sci. 1997; 827 353-368
- 7 Schrezenmeir J. Hyperinsulinemia, hyperproinsulinemia and insulin resistance in the metabolic syndrome. Experientia. 1996; 52 426-432
- 8 Frayn K N, Williams C M, Arner P. Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases?. Clin Sci. 1996; 90 243-253
- 9 Randle P J, Priestman D A, Mistry S, Halsall A. Mechanisms modifying glucose oxidation in diabetes mellitus. Diabetologia. 1994; 37 S155-S161
- 10 Randle P J, Hales C N, Garland P B, Newsholme E A. The glucose fatty-acid cycle, its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963; I 785-789
- 11 Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes. 1997; 46 3-10
- 12 McGarry J D. What if Minkowsky had been ageusic? An alternative angle on diabetes. Science. 1992; 258 766-770
- 13 Reaven G M, Hollenbeck C, Jeng C Y, Wu M S, Chen Y D. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes. 1988; 37 1020-1024
- 14 DeFronzo R A, Bonadonna R C, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 1992; 15 318-368
- 15 Stein D T, Esser V, Stevenson B, et al. Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest. 1996; 97 2728-2735
- 16 Pelkonen R, Miettinen T A, Taskinen M R, Nikkilä E A. Effect of acute elevation of plasma glycerol, triglyceride and FFA levels on glucose utilization and plasma insulin. Diabetes. 1968; 17 76-82
- 17 Balasse E O, Ooms H A. Role of plasma free fatty acids in the control of insulin secretion in man. Diabetologia. 1973; 9 145-151
- 18 Paolisso G, Gambardella A, Amato L, et al. Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia. 1995; 38 1295-1299
- 19 Boden G, Jadali F, White J, et al. Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest. 1991; 88 960-966
- 20 Zhou M Y, Grill V E. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest. 1994; 93 870-876
- 21 Stein D T, Stevenson B E, Chester M W, et al. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest. 1997; 100 398-403
- 22 Boden G, Chen X, Iqbal N. Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects. Diabetes. 1998; 47 1609-1612
- 23 Dobbins R L, Chester M W, Daniels M B, McGarry J D, Stein D T. Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans. Diabetes. 1998; 47 1613-1618
- 24 Unger R H. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes. 1995; 44 863-870
- 25 Herrmann C, Goke R, Richter G, Fehmann H C, Arnold R, Goke B. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion. 1995; 56 117-126
- 26 Creutzfeldt W, Ebert R, Willms B, Frerichs H, Brown J C. Gastric inhibitory polypeptide (GIP) and insulin in obesity: increased response to stimulation and defective feedback control of serum levels. Diabetologia. 1978; 14 15-24
- 27 Brundin T. Whole body and splanchnic metabolic, circulatory, and thermal effects of oral vs. intravenous fat administration. Am J Physiol. 1998; 274 E684-E691
-
28 Lukaski H C.
Body composition assessment using impedance methods. In: Björntorp P, Brodoff BN (eds). Obesity. Philadelphia:; J. B. Lippincott Company, 1992: 67-79 -
29 Bergman R N, Beard J C, Chen M.
The minimal modeling method. Assessment of insulin sensitivity and beta-cell function in vivo. In: Clarke WL, Larner J, Pohl SL (eds). Methods in diabetes research. New York:; John Wiley & Sons, 1986: 15-34 - 30 Yang Y J, Hope I D, Ader M, Bergman R N. Insulin transport across capillaries is rate limiting for insulin action in dogs. J Clin Invest. 1989; 84 1620-1628
- 31 Frayn K N, Shadid S, Hamlani R, et al. Regulation of fatty acid movement in human adipose tissue in the postabsorptive-to-postprandial transition. Am J Physiol. 1994; 266 E308-E317
- 32 Linn T, Ebener K, Laube H, Federlin K. Simultaneous assessment of A- and B-cell function in newly diagnosed insulin-dependent diabetes mellitus. Endocrinol Metab. 1996; 3 117-123
- 33 Seyffert W A, Madison L L. Physiologic effects of metabolic fuels on carbohydrate metabolism. Diabetes. 1967; 16 765-776
- 34 Dobbins R L, Chester M W, Daniels M B, Stein D T, McGarry J D. A fatty-acid dependend step is critically important for both glucose and non-glucose stimulated insulin secretion. J Clin Invest. 1998; 101 2370-2376
- 35 Zhou Y P, Grill V. Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans. J Clin Endocrinol Metab. 1995; 80 1584-1590
- 36 McGarry J D, Dobbins R L. Fatty acids, lipotoxicity and insulin secretion. Diabetologia. 1999; 42 128-138
- 37 Hennes M M, Dua A, Kissebah A H. Effects of free fatty acids and glucose on splanchnic insulin dynamics. Diabetes. 1997; 46 57-62
- 38 Carroll K F, Nestel P J. Effect of long-chain triglyceride on human insulin secretion. Diabetes. 1972; 21 923-929
- 39 Kraegen E W, Chisholm D J, Young J D, Lazarus L. The gastrointestinal stimulus to insulin release. J Clin Invest. 1970; 49 524-529
- 40 Ebert R, Frerichs H, Creutzfeldt W. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance. Eur J Clin Invest. 1979; 9 129-135
- 41 Thorell J, Persson B, Sterkey G. Effect of fat infusion on plasma glucose, FFA, glycerol and insulin levels during i. v. and oral glucose tolerance tests. Diabetologia. 1966; 2 232
- 42 Persson E, Nordenstrom J, Nilsson-Ehle P, Hagenfeldt L, Wahren J. Plasma lipolytic activity and substrate oxidation after intravenous administration of heparin and a low molecular weight heparin fragment. Clin Physiol. 1990; 10 573-583
- 43 Koyama K, Chen G, Lee Y, Unger R H. Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity. Am J Physiol. 1997; 273 E708-E713
- 44 Fernandez J, Valdeolmillos M. Increased levels of free fatty acids in fasted mice stimulate in vivo β-cell electrical activity. Diabetes. 1998; 47 1707-1712
T. Linn,M.D.
Clinical Research Unit
Medical Clinic III and Policlinic
University of Gießen
Rodthohl 6
35392 Gießen, Germany
Telefon: + 49 (641) 99 42841
Fax: + 49 (641) 99 42879
eMail: thomas.linn@innere.med.uni-giessen.de